Form 4 Filing for Aquestive Therapeutics, Inc.

This filing details a stock option grant to Gregory B. Brown, a director at Aquestive Therapeutics, Inc. The option, for 50,500 shares of common stock with a purchase price of $3.99, was granted on June 10, 2026, and vests fully on June 10, 2027, contingent upon continuous service. Following this transaction, Mr. Brown directly owns 75,085 shares of common stock. The filing also includes a power of attorney document authorizing representatives to execute and file necessary SEC forms on behalf of the reporting owner.